Braintree Labs Hit With Antitrust Suit Over MiraLax
A New York drug cooperative has filed a proposed class action against Braintree Laboratories Inc., accusing the drug maker of conspiring to block rivals from marketing a generic version of its...To view the full article, register now.
Already a subscriber? Click here to view full article